ID   CPACr-p
AC   CVCL_F0BY
SY   Canine Pulmonary AdenoCarcinoma RPMI-parental
RX   PubMed=37798461;
CC   Doubling time: 23.0 +- 0.1 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
CH   CVCL_F0BZ ! CPACr-AD4
CH   CVCL_F0C0 ! CPACr-AH4
CH   CVCL_F0C1 ! CPACr-BC9
CH   CVCL_F0C2 ! CPACr-BH12
CH   CVCL_F0C3 ! CPACr-CB2
CH   CVCL_F0C4 ! CPACr-DC3
CH   CVCL_F0C5 ! CPACr-DD10
//
RX   PubMed=37798461; DOI=10.1038/s41598-023-44062-1; PMCID=PMC10556002;
RA   Kobayashi, Kosuke
RA   Takemura, Reika Deja
RA   Miyamae, Jiro
RA   Mitsui, Ikki
RA   Murakami, Kohei
RA   Kutara, Kenji
RA   Saeki, Kohei
RA   Kanda, Teppei
RA   Okamura, Yasuhiko
RA   Sugiyama, Akihiko
RT   "Phenotypic and molecular characterization of novel pulmonary
RT   adenocarcinoma cell lines established from a dog.";
RL   Sci. Rep. 13:16823.1-16823.14(2023).
//